Effects of hormonal contraceptives on sleep - A possible treatment for insomnia in premenopausal women

 

 Permissions and Reprints

Due to the changes that took place since the 1970s, women have achieved important socioeconomic positions. Many tasks, including domestic and familiar ones, continue to be under women’s responsibility, which leads to an overload work. Additionally, the female organism has its peculiarities due to hormonal changes. Adding all these factors up, women seem to be more vulnerable to stressing factors and consequently, might be prone to present several health problems. Within this scenario, one can point out insomnia as a highly prevalent disease among women, directly affecting performance and quality of life. Progesterone has an important effect over sleep, acting both as a hypnogenic and as a respiratory stimulant. Hormonal contraceptives are largely recognized among the modern society women; however, little is known about the effects of these drugs on sleep. This proposal hypothesizes that the use of hormonal contraceptives, mainly those based on progestagens could be a new therapeutic element for the treatment of insomnia and one more tool to be used to improve women´s sleep pattern and quality of life.

Publication History

Received: 14 November 2017

Accepted: 28 June 2018

Article published online:
13 October 2023

© 2023. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

• REFERENCES

• 1 Wallace JE, Young MC. Work hard, play hard?: A comparison of male and female lawyers’ time in paid and unpaid work and participation in leisure activities. Can Rev Sociol. 2010;47(1):27-47.
• 2 Williams K, Kurina LM. The social structure, stress, and women’s health. Clin Obstet Gynecol. 2002;45(4):1099-118.
• 3 Dowbiggin IR. High anxieties: the social construction of anxiety disorders. Can J Psychiatry. 2009;54(7):429-36.
• 4 Richardson JT. The premenstrual syndrome: a brief history. Soc Sci Med. 1995;41(6):761-7.
• 5 Strine TW, Chapman DP, Ahluwalia IB. Menstrual-related problems and psychological distress among women in the United States. J Womens Health (Larchmt). 2005;14(4):316-23.
• 6 Mong JA, Cusmano DM. Sex differences in sleep: impact of biological sex and sex steroids. Philos Trans R Soc Lond B Biol Sci. 2016;371(1688):20150110.
• 7 de Zambotti M, Willoughby AR, Sassoon SA, Colrain IM, Baker FC. Menstrual Cycle-Related Variation in Physiological Sleep in Women in the Early Menopausal Transition. J Clin Endocrinol Metab. 2015;100(8):2918-26.
• 8 Driver HS, Dijk DJ, Werth E, Biedermann K, Borbély AA. Sleep and the sleep electroencephalogram across the menstrual cycle in young healthy women. J Clin Endocrinol Metab. 1996;81(2):728-35.
• 9 Baker FC, Kahan TL, Trinder J, Colrain IM. Sleep quality and the sleep electroencephalogram in women with severe premenstrual syndrome. Sleep. 2007;30(10):1283-91.
• 10 Silva A, Andersen ML, De Mello MT, Bittencourt LR, Peruzzo D, Tufik S. Gender and age differences in polysomnography findings and sleep complaints of patients referred to a sleep laboratory. Braz J Med Biol Res. 2008;41(12):1067-75.
• 11 Hachul H, Bittencourt LR, Andersen ML, Haidar MA, Baracat EC, Tufik S. Effects of hormone therapy with estrogen and/or progesterone on sleep pattern in postmenopausal women. Int J Gynaecol Obstet. 2008;103(3):207-12.
• 12 Hachul H, Andersen ML, Bittencourt LRA, Santos-Silva R, Conway SG, Tufik S. Does the reproductive cycle influence sleep patterns in women with sleep complaints? Climacteric. 2010;13(6):594-603.
• 13 Bittencourt LR, Santos-Silva R, Taddei JA, Andersen ML, de Mello MT, Tufik S. Sleep complaints in the adult Brazilian population: a national survey based on screening questions. J Clin Sleep Med. 2009;5(5):459-63.
• 14 Shechter A, Varin F, Boivin DB. Circadian variation of sleep during the follicular and luteal phases of the menstrual cycle. Sleep. 2010;33(5):647-56.
• 15 Reyner LA, Horne JA, Reyner A. Gender- and age-related differences in sleep determined by home-recorded sleep logs and actimetry from 400 adults. Sleep. 1995;18(2):127-34.
• 16 Groeger JA, Zijlstra FR, Dijk DJ. Sleep quantity, sleep difficulties and their perceived consequences in a representative sample of some 2000 British adults. J Sleep Res. 2004;13(4):359-71.
• 17 Middelkoop HA, Smilde-van den Doel DA, Neven AK, Kamphuisen HA, Springer CP. Subjective sleep characteristics of 1,485 males and females aged 50-93: effects of sex and age, and factors related to self-evaluated quality of sleep. J Gerontol A Biol Sci Med Sci. 1996;51(3):M108-15.
• 18 Lindberg E, Janson C, Gislason T, Björnsson E, Hetta J, Boman G. Sleep disturbances in a young adult population: can gender differences be explained by differences in psychological status? Sleep. 1997;20(6):381-7.
• 19 Guillermo CJ, Manlove HA, Gray PB, Zava DT, Marrs CR. Female social and sexual interest across the menstrual cycle: the roles of pain, sleep and hormones. BMC Womens Health. 2010;10:19.
• 20 Zhang B, Wing YK. Sex differences in insomnia: a meta-analysis. Sleep. 2006;29(1):85-93.
• 21 Ohayon M. Epidemiological study on insomnia in the general population. Sleep. 1996;19(3 Suppl):S7-15.
• 22 Ohayon MM, Hong SC. Prevalence of insomnia and associated factors in South Korea. J Psychosom Res. 2002;53(1):593-600.
• 23 Leger D, Guilleminault C, Dreyfus JP, Delahaye C, Paillard M. Prevalence of insomnia in a survey of 12,778 adults in France. J Sleep Res. 2000;9(1):35-42.
• 24 Kim K, Uchiyama M, Okawa M, Liu X, Ogihara R. An epidemiological study of insomnia among the Japanese general population. Sleep. 2000;23(1):41-7.
• 25 Husby R, Lingjaerde O. Prevalence of reported sleeplessness in northern Norway in relation to sex, age and season. Acta Psychiatr Scand. 1990;81(6):542-7.
• 26 Camhi SL, Morgan WJ, Pernisco N, Quan SF. Factors affecting sleep disturbances in children and adolescents. Sleep Med. 2000;1(2):117-23.
• 27 Li RH, Wing YK, Ho SC, Fong SY. Gender differences in insomnia--a study in the Hong Kong Chinese population. J Psychosom Res. 2002;53(1):601-9.
• 28 Hajak G; SINE Study Group. Study of Insomnia in Europe. Europe Epidemiology of severe insomnia and its consequences in Germany. Eur Arch Psychiatry Clin Neurosci. 2001;251(2):49-56.
• 29 Castro LS, Poyares D, Leger D, Bittencourt L, Tufik S. Objective prevalence of insomnia in the Sao Paulo, Brazil epidemiologic sleep study. Ann Neurol. 2013;74(4):537-46.
• 30 Mong JA, Baker FC, Mahoney MM, Paul KN, Schwartz MD, Semba K, et al. Sleep, rhythms, and the endocrine brain: influence of sex and gonadal hormones. J Neurosci. 2011;31(45):16107-16.
• 31 Gregal RG, Doghramji K. Epidemiology of Insomnia. In: Attarian HP, ed. Clinical Handbook of Insomnia. 3rd ed. New York: Springer; 2017.
• 32 de Campos HH, Bittencourt LR, Haidar MA, Tufik S, Baracat EC. Sleep disturbance prevalence in postmenopausal women. Rev Bras Ginecol Obstet. 2005;27(12):731-6.
• 33 Friess E, Tagaya H, Trachsel L, Holsboer F, Rupprecht R. Progesteroneinduced changes in sleep in male subjects. Am J Physiol. 1997;272(5 Pt 1):E885-91.
• 34 Andersen ML, Bittencourt LR, Antunes IB, Tufik S. Effects of progesterone on sleep: A possible pharmacological treatment for sleep-breathing disorders? Curr Med Chem. 2006;13(29):3575-82.
• 35 Popovic RM, White DP. Upper airway muscle activity in normal women: influence of hormonal status. J Appl Physiol (1985). 1998;84(3):1055-62.
• 36 Lancel M, Faulhaber J, Holsboer F, Rupprecht R. Progesterone induces changes in sleep comparable to those of agonistic GABAA receptor modulators. Am J Physiol. 1996;271(4 Pt 1):E763-72.
• 37 Lancel M, Faulhaber J, Holsboer F, Rupprecht R. The GABA(A) receptor antagonist picrotoxin attenuates most sleep changes induced by progesterone. Psychopharmacology (Berl). 1999;141(2):213-9.
• 38 Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol. 1992;38(4):379-95.
• 39 Paul KN, Laposky AD, Turek FW. Reproductive hormone replacement alters sleep in mice. Neurosci Lett. 2009;463(3):239-43.
• 40 Schwartz MD, Mong JA. Estradiol modulates recovery of REM sleep in a time-of-day-dependent manner. Am J Physiol Regul Integr Comp Physiol. 2013;305(3):R271-80.
• 41 American Psychiatric Association. Diagnostic and Statistic Manual of Mental Disorders. 5th ed. Washington: American Psychiatric Association;2013.
• 42 US Department of Health and Human Services N. NIH State-of-the- Science Conference Statement on manifestations and management of chronic insomnia in adults. NIH Consens State Sci Statements. 2005;22(2):1-30.
• 43 Leger D, Bayon V. Societal costs of insomnia. Sleep Med Rev. 2010;14(6):379-89.
• 44 Stoller MK. Economic effects of insomnia. Clin Ther. 1994;16(5):873-97; discussion 854.
• 45 Gourineni R. Prognosis and complications. In: Attarian HP, ed. Clinical Handbook of Insomnia. 3rd ed. New York: Springer; 2017. p. 59-73.
• 46 Sukys-Claudino L, Moraes WA, Tufik S, Poyares D. [The newer sedativehypnotics]. Rev Bras Psiquiatr. 2010;32(3):288-93. [In Portuguese].
• 47 Rush CR. Behavioral pharmacology of zolpidem relative to benzodiazepines: a review. Pharmacol Biochem Behav. 1998;61(3):253-69.
• 48 Kryger MH, Steljes D, Pouliot Z, Neufeld H, Odynski T. Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem. Sleep. 1991;14(5):399-407.
• 49 Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T; ZOLONG Study Group. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebocontrolled, parallel-group, multicenter study. Sleep. 2008;31(1):79-90.
• 50 Randall S, Roehrs TA, Roth T. Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study. Sleep. 2012;35(11):1551-7.
• 51 Roth T, Eklov SD, Drake CL, Verster JC. Meta-analysis of on-the-road experimental studies of hypnotics: effects of time after intake, dose, and half-life. Traffic Inj Prev. 2014;15(5):439-45.
• 52 MacFarlane J, Morin CM, Montplaisir J. Hypnotics in insomnia: the experience of zolpidem. Clin Ther. 2014;36(11):1676-701.
• 53 Victorri-Vigneau C, Gerardin M, Rousselet M, Guerlais M, Grall-Bronnec M, Jolliet P. An update on zolpidem abuse and dependence. J Addict Dis. 2014;33(1):15-23.
• 54 Eslami-Shahrbabaki M, Barfeh B, Nasirian M. Persistent psychosis after abuse of high dose of zolpidem. Addict Health. 2014;6(3-4):159-62.
• 55 Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH. Association Between Zolpidem and Suicide: A Nationwide Population-Based Case-Control Study. Mayo Clin Proc. 2016;91(3):308-15.
• 56 Wong CK, Marshall NS, Grunstein RR, Ho SS, Fois RA, Hibbs DE, et al. Spontaneous Adverse Event Reports Associated with Zolpidem in the United States 2003-2012. J Clin Sleep Med. 2017;13(2):223-34.
• 57 Miller EH. Women and insomnia. Clin Cornerstone. 2004;6 Suppl 1B:S8-18.
• 58 Krystal AD. Depression and insomnia in women. Clin Cornerstone. 2004;6 Suppl 1B:S19-28.
• 59 Hachul H, Andersen ML, Bittencourt L, Santos-Silva R, Tufik S. A population- based survey on the influence of the menstrual cycle and the use of hormonal contraceptives on sleep patterns in Sao Paulo, Brazil. Int J Gynecol Obstet. 2013;120(2):137-40.
• 60 Baker FC, Mitchell D, Driver HS. Oral contraceptives alter sleep and raise body temperature in young women. Pflugers Arch. 2001;442(5):729-37.
• 61 Baker FC, Waner JI, Vieira EF, Taylor SR, Driver HS, Mitchell D. Sleep and 24 hour body temperatures: a comparison in young men, naturally cycling women and women faking hormonal contraceptives. J Physiol. 2001;530(Pt 3):565-74.
• 62 Polo-Kantola P. Sleep problems in midlife and beyond. Maturitas. 2011;68(3):224-32.
• 63 Wesstrom J, Ulfberg J, Nilsson S. Sleep apnea and hormone replacement therapy: a pilot study and a literature review. Acta Obstet Gynecol Scand. 2005;84(1):54-7.
• 64 Kalleinen N, Polo O, Himanen SL, Joutsen A, Polo-Kantola P. The effect of estrogen plus progestin treatment on sleep: a randomized, placebocontrolled, double-blind trial in premenopausal and late postmenopausal women. Climacteric. 2008;11(3):233-43.
• 65 Leeaunkulsathean E, Pantasri T, Chaovisitseree S, Morakot N. The effect of different progestogens on sleep in postmenopausal women: a randomized trial. Gynecol Endocrinol. 2017;33(12):933-6.
• 66 Caufriez A, Leproult R, L’Hermite-Baleriaux M, Kerkhofs M, Copinschi G. Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women. J Clin Endocrinol Metab. 2011;96(4):E614-23.
• 67 Schussler P, Kluge M, Yassouridis A, Dresler M, Held K, Zihl J, et al. Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women. Psychoneuroendocrinology. 2008;33(8):1124-31.
• 68 Montplaisir J, Lorrain J, Denesle R, Petit D. Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause. 2001;8(1):10-6.
• 69 Bonny AE, Appelbaum H, Connor EL, Cromer B, DiVasta A, Gomez- Lobo V, et al. Clinical variability in approaches to polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2012;25(4):259-61.
• 70 Strowitzki T, Kirsch B, Elliesen J. Efficacy of ethinylestradiol 20 μg/ drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study. J Fam Plann Reprod Health Care. 2012;38(2):94-101.
• 71 Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012;(7):CD004425.
• 72 Schindler AE. Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception. Eur J Obstet Gynecol Reprod Biol. 2004;112(2):136-41.
• 73 Schindler AE. Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metab. 2013;11(1):41-7.
• 74 Giatti S, Melcangi RC, Pesaresi M. The other side of progestins: effects in the brain. J Mol Endocrinol. 2016;57(2):R109-26.
• 75 Hooijmans CR, Ritskes-Hoitinga M. Progress in using systematic reviews of animal studies to improve translational research. PLoS Med. 2013;10(7):e1001482.
• 76 Sena ES, Currie GL, McCann SK, Macleod MR, Howells DW. Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically. J Cereb Blood Flow Metab. 2014;34(5):737-42.
• 77 van Luijk J, Bakker B, Rovers MM, Ritskes-Hoitinga M, de Vries RB, Leenaars M. Systematic reviews of animal studies; missing link in translational research? PLoS One. 2014;9(3):e89981.
• 78 Hachul H, Bezerra AG, Andersen ML. Insomnia and Menopause. In: Attarian HP, ed. Clinical Handbook of Insomnia. 3rd ed. New York: Springer; 2017. p. 181-97.